Guido Ferrari

Preprint · February 6, 2025 BACKGROUND: There is an increased risk of human papillomavirus (HPV)-associated infections and malignancies among people living with HIV (PLHIV). However, there is limited literature exploring the intersection of HPV, HIV, and oral health in Tanzania and a ... Full text Link to item Cite

B cell immunofocusing and repriming in two HIV-1 Env immunization regimens.

Preprint · April 8, 2024 Full text Link to item Cite

Computationally Selected Multivalent HIV-1 Subtype C Vaccine Protects Against Heterologous SHIV Challenge

Preprint · 2024 Background: The RV144 trial in Thailand is the only HIV-1 vaccine efficacy trial to date to demonstrate any efficacy. Genetic signatures suggested antibodies targeting the variable loop 2 (V2) of HIV-1 Envelope played an important protective role ... Full text Cite